Who to call at Recursion Pharmaceuticals, and when
Fundz watches for the moments Recursion Pharmaceuticals starts buying, and tells you who to reach.
- An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.
Contract Type
licensing
Description
On November 26, 2025, Recursion Pharmaceuticals filed a prospectus to register for resale 7,088,742 shares of Class A common stock issued to Tempus AI, Inc. as part of the payment for annual license fees under a Master Agreement. This prospectus is associated with Recursion's automatic shelf Registration Statement previously filed with the SEC. The transaction highlights Recursion's ongoing collaboration with Tempus.
Quick answer
Recursion Pharmaceuticals Registers Shares for Resale in Tempus Agreement (November 26, 2025). Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.
- What agreement did Recursion Pharmaceuticals announce on November 26, 2025?
- On November 26, 2025, Recursion Pharmaceuticals filed a prospectus to register for resale 7,088,742 shares of Class A common stock issued to Tempus AI, Inc. as part of the payment for annual license fees under a Master Agreement. This prospectus is associated with Recursion's automatic shelf Registration Statement previously filed with the SEC.
- What does Recursion Pharmaceuticals do?
- Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs.
- Where is Recursion Pharmaceuticals based?
- Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.
Source: Fundz verified event record.
Related People
Recursion Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.